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SEVERAL enteritis/enterotoxaemia syndromes in mammals and birds 
are the consequence of an uncontrolled overgrowth of Clostridium per-
fringens invading the small intestine from the caecum and the colon 
and producing different exotoxins. In suckling beef calves the α, or 
CPA, and β2, or CPB2, major toxins act in synergy to produce intes-
tinal necrohaemorrhagic lesions. The CPA toxin subsequently trans-
fers into the bloodstream and reaches the brain, causing sudden death 
(Manteca and Daube 1994, Songer 1996, Manteca and others 2002, 
Smedley and others 2004, Uzal and Songer 2008, Cooper and Songer 
2009, Popoff and Bouvet 2009, van Asten and others 2010).
Different alleles of the cpb2 gene have been identified and grouped 
into the consensus (cpb2con) and the atypical (cpb2aty) variants. While the 
atypical variant is more common in healthy individuals, the consensus 
variant can become more common in diseased animals. In newborn 
piglets with necrotic enteritis, 90 per cent of C perfringens isolates har-
bour the cpb2con gene. A similar observation has recently been reported 
in suckling beef calves with enterotoxaemia, but not in other animal 
species, or in human beings (Gibert and others 1997, Bueschel and 
others 2003, Fisher and others 2005, Jost and others 2005, Lebrun and 
others 2007, van Asten and others 2010).
Cases of enterotoxaemia-like syndrome with sudden death and 
lesions of haemorrhagic enteritis of the small intestine are also frequent 
in the veal calf industry, especially in calves belonging to beef cattle 
breeds (Manteca and others 2001). The present study took place on a 
Belgian farm with a production of approximately 120,000 veal calves 
per year, of which 75 per cent belonged to the Belgian blue breed. The 
aim was to isolate and toxin-type C perfringens from such cases, with spe-
cial reference to the identification of the cpb2 gene variant(s) present.
Eighteen Belgian blue veal calves without any clinical signs 
observed before death, but with gaseous dilation, haemorrhagic 
lesions, and liquid and haemorrhagic contents in the small intestine 
at postmortem examination performed within a few hours after 
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death, were sampled; these animals are thereafter referred to as the 
case calves. For each animal, a small intestinal loop with lesions was 
removed, stored in a jar in anaerobic conditions (Anaerocult; Merck) 
and transported to the laboratory to perform bacteriological analysis, 
as described by Lebrun and others (2007).
Six of the case calves (33 per cent) had high C perfringens counts 
(>106 cfu/ml of intestinal content) and five (28 per cent) had interme-
diate counts (between 103 and 106 cfu/ml of intestinal content) (Table 
1). No C perfringens growth (<10 cfu/ml of intestinal content) was 
observed from the intestinal contents of the other seven case calves 
(39 per cent). Of the 11 case calves with intermediate or high cfu, 77 C 
perfringens isolates were collected from the intestinal contents of nine 
animals, but the plates were overgrown by enterococci for the remain-
ing two (calves 4 and 5) (Table 1). Fifteen isolates of C perfringens were 
also collected at the slaughterhouse of the farm from the small intesti-
nal contents of four six-month-old healthy veal calves with <103 cfu/
ml of intestinal content (the control calves and isolates) (Table 1).
All 92 C perfringens isolates tested positive with a PCR targeting 
the cpa gene and negative with PCRs targeting the cpb, etx, iap and cpe 
genes coding for the β, ε and ι major toxins and for the enterotoxin, 
respectively (Daube and others 1994, Braun and others 2000, Albini 
and others 2008). Nineteen of the case isolates (25 per cent) from four 
calves (44 per cent) and none of the control isolates tested positive 
with the PCR targeting the cpb2 gene family (Van Asten and others 
2008). The relative frequency of cpb2-positive isolates varied from one 
isolate out of 12 (calf 6) up to all 10 isolates from calf 10 (Table 1). 
Five isolates from calves 6, 11 and 8 tested positive with three PCRs 
targeting the cpb2con gene (Herholz and others 1999, Jost and others 
2005, Van Asten and others 2008), while the remaining 14 isolates 
from calves 10 and 8 tested positive with one of two PCRs targeting 
the cpb2aty gene (Jost and others 2005) (Table 1). The second cpb2aty 
gene PCR (Van Asten and others 2008) did not give any results, even 
with the control strains, despite several changes of experimental con-
ditions (data not shown). The sequencing of all amplified fragments 
confirmed the presence of the cpb2con gene and of the cpb2aty gene.
According to these results, neither CPB2 toxin nor the CBP2con 
variant appears to have been involved in the enterotoxaemia-like syn-
TABLE 1: PCR results on 77 Clostridium perfringens isolates from 
calves affected with an enterotoxaemia-like syndrome (cases) 
and on 15 C perfringens isolates from control calves for the cpb2 
gene family and for the cpb2con and cpb2aty gene variants
Calves Lesions
C perfringens  
count (cfu) Calf






Case Typical ≥106  1 10 – –
 2  8 – –
 3 12 – –
 4 12 ND ND
 5 12 ND ND
103-105  6 12  1 Consensus
 7  4 – –
 8 12  6 Atypical (4)
Consensus (2)
Suspicious ≥106  9  2 – –
103-105 10 10 10 Atypical
11  7  2 Consensus
Control Absent 101-103 12  3 – –
13  4 – –
14  3 – –
15  5 – –
* All colonies tested positive with the PCR targeting the cpa gene coding for the α toxin 
and negative with the PCRs targeting the cpb, etx, iap and cpe genes coding for the β, 
ε and ι major toxins and for the enterotoxin
ND Not done (no colony was tested due to enterococcal overgrowth of the plates)
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drome in these veal calves. This is in contrast with results obtained 
during a study in suckling beef calves in which two-thirds of C per-
fringens isolates (28 of 41) from 14 case calves were cpb2-positive and 
all 28 harboured the cpb2con gene (Lebrun and others 2007). This sug-
gests that C perfringens may not have even been associated with the 
enterotoxaemia-like syndrome in the veal calves in the present study 
since only one-third (six of 18) of the case calves had high counts of C 
perfringens (>106 cfu/ml of intestinal content). In contrast, in a study by 
Manteca and others (2001), 79 per cent (62 of 79) of the suckling beef 
calves had high counts of C perfringens.
However, rapid upregulation of toxin production by C perfringens 
has been reported upon contact with host enterocytes (Vidal and 
others 2009, McClane 2010). Therefore, high counts of C perfrin-
gens are not necessary to cause an enterotoxaemia-like syndrome 
if a subpopulation of cpb2-positive C perfringens rapidly produces 
large amounts of the CPBcon toxin, which is 10 times as toxic as the 
CPB2aty variant. It is therefore possible that the cpb2-negative case 
calves harboured a cpb2con-positive C perfringens population below the 
detection level of the authors’ methodology. This might also explain 
the higher proportion of cpb2aty-positive than cpb2con-positive isolates 
in each of the cpb2-positive calves (Table 1).
Interestingly, all 19 cpb2-positive colonies were isolated from the 
four calves with 103 to 105 cfu of C perfringens per ml of intestinal con-
tent and not from the calves with more than 106 cfu of C perfringens 
(Table 1). Although there is no straightforward explanation, it is pos-
sible to speculate that the intensive use of antibiotics in the veal calf 
industry directly or indirectly impaired the C perfringens growth and/or 
rendered the plasmid carrying the cpb2 genes more unstable in vitro. A 
larger study in more farms is required.
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